Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data.
Strober B, Leonardi C, Papp KA, Mrowietz U, Ohtsuki M, Bissonnette R, Ferris LK, Paul C, Lebwohl M, Braun DK, Mallbris L, Wilhelm S, Xu W, Ljungberg A, Acharya N, Reich K. Strober B, et al. Among authors: reich k. J Am Acad Dermatol. 2017 Mar;76(3):432-440.e17. doi: 10.1016/j.jaad.2016.09.026. Epub 2016 Nov 23. J Am Acad Dermatol. 2017. PMID: 27889292 Free article.
[Therapy of psoriasis-arthritis and psoriasis vulgaris with infliximab].
Mrowietz U, Barth J, Boehncke WH, Reich K, Rosenbach T, Streit V, Wozel G. Mrowietz U, et al. Among authors: reich k. J Dtsch Dermatol Ges. 2006 May;4(5):444-7. doi: 10.1111/j.1610-0387.2006.05886.x. J Dtsch Dermatol Ges. 2006. PMID: 16686615 German. No abstract available.
[Therapy of psoriasis vulgaris with efalizumab].
Mrowietz U, Barth J, Boehncke WH, Reich K, Rosenbach T, Streit V, Wozel G. Mrowietz U, et al. Among authors: reich k. J Dtsch Dermatol Ges. 2006 Jun;4(6):511-2. doi: 10.1111/j.1610-0387.2006.05885.x. J Dtsch Dermatol Ges. 2006. PMID: 16734844 German. No abstract available.
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).
Nast A, Kopp I, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B. Nast A, et al. Among authors: reich k. Arch Dermatol Res. 2007 Jun;299(3):111-38. doi: 10.1007/s00403-007-0744-y. Epub 2007 May 12. Arch Dermatol Res. 2007. PMID: 17497162 Free PMC article. Review.
Treatment goals in psoriasis.
Reich K, Mrowietz U. Reich K, et al. J Dtsch Dermatol Ges. 2007 Jul;5(7):566-74. doi: 10.1111/j.1610-0387.2007.06343.x. J Dtsch Dermatol Ges. 2007. PMID: 17610606 Review. English, German.
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).
Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N, Guzzo C, Hsu MC, Wang Y, Li S, Dooley LT, Reich K; PHOENIX 2 study investigators. Papp KA, et al. Among authors: reich k. Lancet. 2008 May 17;371(9625):1675-84. doi: 10.1016/S0140-6736(08)60726-6. Lancet. 2008. PMID: 18486740 Clinical Trial.
584 results